Publishing research using ab103477? Please let us know so that we can cite the reference in this datasheet.

ab103477 has been referenced in 2 publications.

  • Zhao H  et al. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy. Jpn J Clin Oncol 46:893-902 (2016). PubMed: 27432453
  • Liu Z  et al. Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells. Oncol Lett 12:3944-3948 (2016). WB ; Human . PubMed: 27895754

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up